When was ONWARD founded?

ONWARD was founded in 2014 and raised its 1st funding round within a year of its incorporation.

Where is ONWARD located?

ONWARD is headquartered in Eindhoven, Netherlands.

How many employees does ONWARD have?

As of Jun 30, 2026, the latest employee count at ONWARD is 205.

Is ONWARD a funded company?

ONWARD is a funded company, having raised a total of $35M across 13 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Aug 01, 2014.

When was the latest funding round of ONWARD?

ONWARD's latest funding was a $***** Post IPO round on Apr 16, 2026, with participation from 1 investor.

Where does ONWARD rank among its competitors?

ONWARD ranks 4th amongst 81 active competitors, of which 24 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was BlueWind Medical, which secured $47.8M in May, 2026.

Who are the top competitors of ONWARD?

ONWARD's top competitors include ElectroCore, SetPoint Medical and Synchron. Among them, BlueWind Medical secured the most recent funding round in May, 2026.

ONWARD - 2026 Company Profile, Team, Funding & Competitors

ONWARD is a public company based in Eindhoven (Netherlands), founded in 2014. It operates as a Developer of a therapeutic device for spinal cord injuries. ONWARD has raised $35M in funding from Olympic Investment and Invest-NL. The company has 81 active competitors, including 24 funded and 10 that have exited. Its top competitors include companies like ElectroCore, SetPoint Medical and Synchron.

Company Details

Developer of a therapeutic device for spinal cord injuries. The company's ARC therapy is delivered by implantable or external systems as programmed stimulation of the spinal cord that helps restore movement and other functions associated with the spinal cord.

Website: www.onwd.com/
Social
Email ID: *****@onwd.com

Key Metrics

Founded Year

2014

Location

Eindhoven, Netherlands

Stage

Public

Total Funding

$35M in 13 rounds

Latest Funding Round

Post IPO, Apr 16, 2026, $*****

Investors

Olympic Investment & 18 more

Ranked

4^th among 81 active competitors

Employee Count

205 as on Jun 30, 2026

Similar Companies

ElectroCore & 88 more

Exit Details

Public

View ONWARD's full profile

ONWARD got listed on Oct 21, 2021.

Click here to take a look at ONWARD's IPO in detail

ONWARD has raised a total funding of $35M over 13 rounds. Its first funding round was on Aug 01, 2014. Its latest funding round was a Post IPO round on Apr 16, 2026 for $*****. 1 investor participated in its latest round. ONWARD has 19 institutional investors.

Here is the list of recent funding rounds of ONWARD:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 16, 2026	6396341	Post IPO	2006971	9055922	1171712	7146225
Oct 28, 2025	7614175	Post IPO	6789974	1464803	2167379	4635203
Nov 19, 2024	5635344	Grant (prize money)	6087772	3367888	8571295	Europa

Access funding benchmarks and valuations. Sign up today!

View details of ONWARD's funding rounds and investors

ONWARD's employee count trend

ONWARD has 205 employees as of Jun 26. Here is ONWARD's employee count trend over the years:

Uncover ONWARD's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ONWARD include ElectroCore, SetPoint Medical and Synchron. Here is the list of Top 10 competitors of ONWARD, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ElectroCore 2005, Basking Ridge (United States), Public	Developer of non-invasive vagus nerve stimulation devices	$161M	Core Ventures Group, Merck Global Health Innovation Fund ... & 6 others	70/100
2nd	SetPoint Medical 2006, Santa Clarita (United States), Series F	Developer of implantable neuromodulation devices for inflammatory diseases	$388M	Norwest, Medtronic & 32 others	64/100
3rd	Synchron 2016, Brooklyn (United States), Series D	Developer of implantable bioelectronics for the treatment of neurological conditions	$345M	Arch Venture Partners, Khosla Ventures & 33 others	62/100
4th	ONWARD 2014, Eindhoven (Netherlands), Public	Developer of a therapeutic device for spinal cord injuries	$35M	Life Sciences Partners, EQT & 17 others	61/100
5th	Nalu Medical 2014, Carlsbad (United States), Acquired	Developer of a neurostimulation system for managing intractable chronic pain	$231M	Gilde Healthcare, Novo Holdings & 9 others	61/100
6th	Neurovalens 2013, Belfast (United Kingdom), Series A	Developer of non-invasive neurostimulation products	$26.1M	IQ Capital, ACF Investors & 57 others	57/100
7th	SpineX 2018, Los Angeles (United States), Seed	Developer of a medical device for neurological conditions	-	NIH, UCSF Rosenman Institute & 2 others	52/100
8th	BlueWind Medical 2010, Herzliya (Israel), Series B	Developer of neurostimulation device for the treatment of overactive bladder	$112M	ConvaTec, Rainbow Medical	49/100
9th	Subsense 2022, Covina (United States), Seed	Developer of non-surgical brain-computer interfaces using biocompatible nanoparticles	$27M	Golden Falcon Capital	48/100
10th	Atlantic Therapeutics 2013, Oranmore (Ireland), Acquired	Developer of a non-invasive wearable device for pelvic floor strengthening and nerve stimulation products	$70.6M	Life Sciences Partners, Western Development Commission ... & 10 others	48/100